Northrop Grumman Corporation
NOCLast close · Oct 16, 2026519.86+20.23 (+4.05%)
Market cap$73.9B
9 firms' latest targets, last 90 days: median $612.00 ($419.00–$704.00), 18% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-14 | Bernstein | $556.00 | ▼ 10% | +7% |
| 2026-10-08 | Barclays | $419.00 | — | -19% |
| 2026-10-06 | Rothschild & Co Redburn | $680.00 | — | +31% |
| 2026-10-02 | RBC Capital | $525.00 | ▼ 30% | +1% |
| 2026-09-14 | Guggenheim | $612.00 | — | +18% |
| 2026-09-08 | UBS | $704.00 | ▼ 6% | +35% |
| 2026-07-22 | Deutsche Bank | $615.00 | ▼ 20% | +18% |
| 2026-07-22 | Susquehanna | $655.00 | ▼ 13% | +26% |
| 2026-07-22 | Baird | $500.00 | — | -4% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2023reported | $39.3B | +7% | $13.53 | -57% | est. $39.1B+0% | est. $22.81 | 14 |
| 2024reported | $41.0B | +4% | $28.34 | +109% | est. $41.3B-1% | est. $26.04 | 15 |
| 2025reported | $42.0B | +2% | $29.08 | +3% | est. $41.9B+0% | est. $26.06 | 14 |
| 2026 | $44.1B | +5% | $28.93 | +11% | $43.8B–$44.3B | $28.06–$29.30 | 18 |
| 2027 | $47.1B | +7% | $30.36 | +5% | $46.5B–$48.0B | $29.47–$31.76 | 17 |
| 2028 | $50.0B | +6% | $32.83 | +8% | $47.8B–$51.7B | $29.83–$34.78 | 20 |
| 2029 | $52.2B | +4% | $35.05 | +7% | $51.2B–$53.1B | $34.20–$35.79 | 10 |
| 2030 | $54.7B | +5% | $37.34 | +7% | $53.7B–$55.6B | $36.44–$38.13 | 10 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.